These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25797234)

  • 1. Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
    Canlorbe G; Matheron S; Mandelbrot L; Oudet B; Luton D; Azria E
    Am J Obstet Gynecol; 2015 Aug; 213(2):241.e1-9. PubMed ID: 25797234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV RNA viral load and CD4+ T-cell counts in HIV-infected pregnant women with and without treatment discontinuation in early pregnancy.
    Tamburrini E; Ravizza M; Floridia M; Tibaldi C; Alberico S; Anzidei G; Maccabruni A; Meloni A; Antoni AD; Mori F; Dalzero S; Conservan V; Pinnetti C; Ferrazzi E;
    Antivir Ther; 2008; 13(4):519-27. PubMed ID: 18672530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does human immunodeficiency virus infection protect against preeclampsia-eclampsia?
    Frank KA; Buchmann EJ; Schackis RC
    Obstet Gynecol; 2004 Aug; 104(2):238-42. PubMed ID: 15291993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011.
    Ewing AC; Datwani HM; Flowers LM; Ellington SR; Jamieson DJ; Kourtis AP
    Am J Obstet Gynecol; 2016 Oct; 215(4):499.e1-8. PubMed ID: 27263995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
    Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-eclampsia, antiretroviral therapy, and immune reconstitution.
    Wimalasundera RC; Larbalestier N; Smith JH; de Ruiter A; McG Thom SA; Hughes AD; Poulter N; Regan L; Taylor GP
    Lancet; 2002 Oct; 360(9340):1152-4. PubMed ID: 12387967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Jan; 47(RR-2):1-30. PubMed ID: 9461044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester maternal uterine artery Doppler examination in HIV-positive women.
    Savvidou MD; Samuel MI; Akolekar R; Poulton M; Nicolaides KH
    HIV Med; 2011 Nov; 12(10):632-6. PubMed ID: 21569189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.
    Berends AL; de Groot CJ; Sijbrands EJ; Sie MP; Benneheij SH; Pal R; Heydanus R; Oostra BA; van Duijn CM; Steegers EA
    Hypertension; 2008 Apr; 51(4):1034-41. PubMed ID: 18259037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective study of HIV, antiretroviral therapy, and pregnancy-associated hypertension among women in Lusaka, Zambia.
    Stoner MC; Vwalika B; Smid MC; George S; Chi BH; Stringer EM; Stringer JS
    Int J Gynaecol Obstet; 2016 Sep; 134(3):299-303. PubMed ID: 27365290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?
    Villar J; Carroli G; Wojdyla D; Abalos E; Giordano D; Ba'aqeel H; Farnot U; Bergsjø P; Bakketeig L; Lumbiganon P; Campodónico L; Al-Mazrou Y; Lindheimer M; Kramer M;
    Am J Obstet Gynecol; 2006 Apr; 194(4):921-31. PubMed ID: 16580277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome among HIV positive women receiving antenatal HAART versus untreated maternal HIV infection.
    Joseph O; Biodun O; Michael E
    J Coll Physicians Surg Pak; 2011 Jun; 21(6):356-9. PubMed ID: 21711992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of fetal growth in maternal HIV disease.
    Iqbal SN; Kriebs J; Harman C; Alger L; Kopelman J; Turan O; Gungor S; Malinow A; Baschat AA
    Am J Perinatol; 2010 Aug; 27(7):517-23. PubMed ID: 20200807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does pregnancy affect the early response to cART?
    Rachas A; Warszawski J; Le Chenadec J; Legeai C; Teglas JP; Goujard C; Rouzioux C; Mandelbrot L; Tubiana R; Meyer L
    AIDS; 2013 Jan; 27(3):357-67. PubMed ID: 23079802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
    Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R; Senise J; Vaz M; Diaz R; Castelo A
    HIV Med; 2009 Mar; 10(3):157-62. PubMed ID: 19245537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.